Author

Qi‐Xiang Li

Observed name: Qi-Xiang Li

Observed institutions: Peking University, Crown Bioscience (China), State Key Laboratory of Natural and Biomimetic Drugs

OpenAlex ID: A5040744767

NSCLC harboring EGFR exon‐20 insertions after the regulatory C ‐helix of kinase domain responds poorly to known EGFR inhibitors

2016 · Mengmeng Yang, Xiaoxi Xu, et al. · International Journal of Cancer · 55

Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes

2022 · Sung Hwan Lee, Sun Young Yim, et al. · Hepatology · 30

Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signature

2016 · Sheng Guo, Dawei Chen, et al. · Oncotarget · 13

Works count: 3

Citation count: 98

H-index: 3

I10-index: 3